255165
三丁基甲基氯化铵 溶液
75 wt. % in H2O
别名:
甲基三丁基氯化铵 溶液
登录 查看组织和合同定价。
选择尺寸
关于此项目
线性分子式:
CH3N[CH3(CH2)3]3Cl
化学文摘社编号:
分子量:
235.84
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352116
MDL number:
InChI
1S/C13H30N.ClH/c1-5-8-11-14(4,12-9-6-2)13-10-7-3;/h5-13H2,1-4H3;1H/q+1;/p-1
SMILES string
[Cl-].CCCC[N+](C)(CCCC)CCCC
InChI key
IPILPUZVTYHGIL-UHFFFAOYSA-M
vapor pressure
7.9 mmHg ( 25 °C)
Quality Level
assay
77.2%
form
liquid
concentration
75 wt. % in H2O
refractive index
n20/D 1.4682
bp
152 °C
density
0.964 g/mL at 25 °C
General description
三丁基甲基氯化铵(TBMAC)是一种季铵盐，常用作各种有机合成反应的相转移催化剂。也用于制备离子液体。
Application
三丁基甲基氯化铵溶液可作为相转移催化剂，用于在KHSO5氧化剂存在下，经由环己酮的Baeyer-Villiger氧化反应合成ɛ-己内酯。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Dermal - Aquatic Chronic 2 - Eye Irrit. 2 - Skin Irrit. 2
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type ABEK (EN14387) respirator filter
Enantioselective biocatalytic reduction of 2 H-1, 4-benzoxazines using imine reductases
Zumbra?gel N, et al.
The Journal of Organic Chemistry, 84(3), 1440-1447 (2018)
New and efficient technique for the synthesis of ?-caprolactone using KHSO5 as an oxidising agent in the presence of a phase transfer catalyst
Baj S, et al.
Applied Catalysis A: General, 395(1-2), 49-52 (2011)
Paula Ossowicz et al.
Molecules (Basel, Switzerland), 24(18) (2019-09-11)
Ionic liquids based on different l-amino acids (glycine, l-valine, l-leucine, l-isoleucine, l-histidine, l-methionine, l-tyrosine, l-tryptophan, l-arginine, and l-threonine) and different cations (tetrabutylammonium (TBA), tributylmethylammonium (tBMA), didecyldimethylammonium (DDA), (2-hydroxyethyl)trimethylammonium (choline) (Chol), alkyl(C12-C14) dimethylbenzylammonium (benzalkonium) (BA), dodecyltrimethylammonium (DDTMA), hexadecyltrimethylammonium (HDTMA), octadecyltrimethylammonium (ODTMA)
Soon-Sun Hong et al.
Archives of pharmacal research, 29(4), 318-322 (2006-05-10)
Many quaternary ammonium salts are incompletely absorbed after their oral administration and may also be actively secreted into the intestine. However, the underlying mechanism(s) that control the transport of these cations across the intestinal epithelium is not well understood. In
J W Smit et al.
The Journal of pharmacology and experimental therapeutics, 286(1), 321-327 (1998-07-10)
We recently showed that absence of mdr1-type P-glycoprotein (P-gp) in mice resulted in profoundly reduced hepatic and intestinal clearance of type 1 and type 2 cationic drugs compared with that in wild-type mice. These data strongly support the concept that
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持